[go: up one dir, main page]

ZA200107716B - Disodium salts, monohydrates and ethanol solvates. - Google Patents

Disodium salts, monohydrates and ethanol solvates.

Info

Publication number
ZA200107716B
ZA200107716B ZA200107716A ZA200107716A ZA200107716B ZA 200107716 B ZA200107716 B ZA 200107716B ZA 200107716 A ZA200107716 A ZA 200107716A ZA 200107716 A ZA200107716 A ZA 200107716A ZA 200107716 B ZA200107716 B ZA 200107716B
Authority
ZA
South Africa
Prior art keywords
monohydrates
disodium salts
ethanol solvates
solvates
ethanol
Prior art date
Application number
ZA200107716A
Other languages
English (en)
Inventor
William E Bay
Rajesh K Agarwal
Kiran Chaudhary
Signai Majuru
Micheal M Goldberg
Joanne P Russo
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of ZA200107716B publication Critical patent/ZA200107716B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ZA200107716A 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates. ZA200107716B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12775499P 1999-04-05 1999-04-05

Publications (1)

Publication Number Publication Date
ZA200107716B true ZA200107716B (en) 2003-08-18

Family

ID=22431779

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200309114A ZA200309114B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.
ZA200107716A ZA200107716B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200309114A ZA200309114B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.

Country Status (3)

Country Link
AU (1) AU4218400A (fr)
WO (1) WO2000059480A1 (fr)
ZA (2) ZA200309114B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344213B1 (en) 1996-03-29 2002-02-05 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU5471199A (en) 1998-08-07 2000-02-28 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7151191B2 (en) 2000-01-13 2006-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CZ303736B6 (cs) 2000-06-29 2013-04-17 Emisphere Technologies, Inc. Slouceniny a prostredky pro zavádení aktivních cinidel
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
TWI307279B (en) 2002-08-01 2009-03-11 Novartis Ag Oral administration of calcitonin
NZ551455A (en) 2004-05-19 2012-03-30 Emisphere Tech Inc Acyclovir formulations
AU2005244986B2 (en) 2004-05-19 2011-01-27 Emisphere Technologies, Inc. Topical cromolyn formulations
AU2005321803B2 (en) 2004-12-29 2012-02-09 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (fr) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions pour l'administration orale de l'hormone parathyroide
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
WO2007121318A2 (fr) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Préparations destinées à l'administration d'insuline
US9364502B2 (en) 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations
AU2008223108B2 (en) 2007-03-02 2013-10-10 Novartis Ag Oral administration of a calcitonin
WO2011017346A2 (fr) 2009-08-03 2011-02-10 Emisphere Technologies, Inc. Composition de naproxène à action rapide avec effets gastro-intestinaux réduits

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient

Also Published As

Publication number Publication date
ZA200309114B (en) 2005-02-23
WO2000059480A1 (fr) 2000-10-12
AU4218400A (en) 2000-10-23

Similar Documents

Publication Publication Date Title
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA99254B (en) Benzosulfone derivatives.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
ZA9811339B (en) Benzamidine derivatives.
ZA200203834B (en) Adamantane derivatives.
ZA98362B (en) 3-heterocyclyl-substituted benzoyl derivatives.
ZA200309114B (en) Disodium salts, monohydrates and ethanol solvates.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA978045B (en) New benzamidine derivatives.
ZA200201829B (en) New phenylpiperazines.
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
ZA991550B (en) Cyclohexanediole derivatives.
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
ZA982436B (en) Thiazolimine derivatives.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
MXPA01011285A (es) Derivados de tio-oxindol.
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
CY2322B1 (en) Benzoaeguequinoline derivatives.